ArticleThe Lancet. Oncology2022
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC.
Joe Y Chang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it
ArticleThe Lancet. Oncology2022
Joe Y Chang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.